Galvanize, Pfizer Consumer Healthcare work together to assist healthcare startups

Galvanize and Pfizer Consumer Healthcare (PCH) have announced a health and wellness innovation program that gives startup companies access to the Galvanize network of talent and investors. The program will seek out startups working on developing “potential solutions for improved sleep, stress management, energy, aging and nutrition.”

The first startups will be selected by Galvanize and PCH for a six-month program beginning in March. Jim Deters, Galvanize co-founder and CEO, said in a prepared statement that both companies are looking forward to assisting these startups as they work toward their goals.

“We're excited to team up with a leader in healthcare such as Pfizer Consumer Healthcare to foster innovation in the health and tech industry,” Deters said. “This program will provide an amazing environment for healthcare startups to grow and reach their full potential, and is proof of Galvanize's ability to provide great technical talent and invaluable resources for founders."

“Developing new ways for consumers to improve their health and well-being remains a priority for Pfizer Consumer Healthcare,” Suneet Varma, PCH president and general manager, said in the same statement. “Collaborating with new partners enables us to build on our own efforts to develop new, innovative ways for consumers to achieve better health and wellness by tapping into the creativity and thinking taking place all around us.”

Startups selected for the program will meet with Galvanize representatives weekly, and they will also be able to pitch their ideas to students from Galvanize’s Full Stack and Data Science programs.

Individuals interested in submitting their startup’s information for consideration have until Feb. 23. Additional information is located on Galvanize’s website

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”